Skip to main content

Research Repository

Advanced Search

Lung cancer stage-shift following a symptom awareness campaign

Kennedy, Martyn; Cheyne, Leanne; Darby, Michael; Plant, Paul; Milton, Richard; Robson, Jonathan; Gill, Alison; Malhotra, Puneet; Ashford-Turner, Victoria; Rodger, Kirsty; Paramasivam, Elankumaran; Johnstone, Annette; Bhartia, Bobby; Karthik, Shishir; Foster, Catherine; Lovatt, Veronica; Hewitt, Francesca; Cresswell, Louise; Coupland, Victoria H.; Lüchtenborg, Margreet; Jack, Ruth H.; Møller, Henrik; Callister, Matthew E.

Lung cancer stage-shift following a symptom awareness campaign Thumbnail


Authors

Martyn Kennedy

Leanne Cheyne

Michael Darby

Paul Plant

Richard Milton

Jonathan Robson

Alison Gill

Puneet Malhotra

Victoria Ashford-Turner

Kirsty Rodger

Elankumaran Paramasivam

Annette Johnstone

Bobby Bhartia

Shishir Karthik

Catherine Foster

Veronica Lovatt

Francesca Hewitt

Louise Cresswell

Victoria H. Coupland

Margreet Lüchtenborg

RUTH JACK Ruth.Jack@nottingham.ac.uk
Senior Research Fellow

Henrik Møller

Matthew E. Callister



Abstract

Background: Lung cancer outcomes in the UK are worse than in many other developed nations. Symptom awareness campaigns aim to diagnose patients at an earlier stage to improve cancer outcomes.

Methods: An early diagnosis campaign for lung cancer commenced in Leeds, UK in 2011 comprising public and primary-care facing components. Rates of community referral for chest X-ray and lung cancer stage (TNM seventh edition) at presentation were collected from 2008 to 2015. Linear trends were assessed by χ2 test for trend in proportions. Headline figures are presented for the 3 years pre-campaign (2008–2010) and the three most recent years for which data are available during the campaign (2013–2015).

Findings: Community-ordered chest X-ray rates per year increased from 18 909 in 2008–2010 to 34 194 in 2013–2015 (80.8% increase). A significant stage shift towards earlier stage lung cancer was seen (χ2(1)=32.2, p[less than]0.0001). There was an 8.8 percentage point increase in the proportion of patients diagnosed with stage I/II lung cancer (26.5% pre-campaign vs 35.3% during campaign) and a 9.3% reduction in the absolute number of patients diagnosed with stage III/IV disease (1254 pre-campaign vs 1137 during campaign).

Interpretation: This is the largest described lung cancer stage-shift in association with a symptom awareness campaign. A causal link between the campaign and stage-shift cannot be proven but appears plausible. Limitations of the analysis include a lack of contemporary control population.

Citation

Kennedy, M., Cheyne, L., Darby, M., Plant, P., Milton, R., Robson, J., …Callister, M. E. (2018). Lung cancer stage-shift following a symptom awareness campaign. Thorax, 73(12), 1128-1136. https://doi.org/10.1136/thoraxjnl-2018-211842

Journal Article Type Article
Acceptance Date Jun 4, 2018
Online Publication Date Jun 27, 2018
Publication Date 2018-12
Deposit Date Jul 26, 2018
Publicly Available Date Jul 26, 2018
Journal Thorax
Print ISSN 0040-6376
Electronic ISSN 1468-3296
Publisher BMJ Publishing Group
Peer Reviewed Peer Reviewed
Volume 73
Issue 12
Pages 1128-1136
DOI https://doi.org/10.1136/thoraxjnl-2018-211842
Keywords Lung Cancer; Symptom Awareness
Public URL https://nottingham-repository.worktribe.com/output/942150
Publisher URL https://thorax.bmj.com/content/early/2018/06/27/thoraxjnl-2018-211842
Additional Information This article has been accepted for publication in Thorax, 2018 following peer review, and the Version of Record can be accessed online at http://dx.doi.org/10.1136/thoraxjnl-2018-211842